UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · Real-Time Price · USD
220.04
+10.19 (4.86%)
At close: Nov 21, 2025, 4:00 PM EST
219.98
-0.06 (-0.03%)
After-hours: Nov 21, 2025, 5:06 PM EST
UFP Technologies Market Cap
UFP Technologies has a market cap or net worth of $1.7 billion as of November 21, 2025. Its market cap has decreased by -35.67% in one year.
Market Cap
1.70B
Enterprise Value
1.84B
1-Year Change
-35.67%
Ranking
Category
Stock Price
$220.04
Market Cap Chart
Since December 1, 1998, UFP Technologies's market cap has increased from $15.40M to $1.70B, an increase of 10,916.78%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 1.70B | -9.59% |
| Dec 31, 2024 | 1.88B | 42.79% |
| Dec 29, 2023 | 1.31B | 47.10% |
| Dec 30, 2022 | 893.40M | 68.82% |
| Dec 31, 2021 | 529.20M | 51.50% |
| Dec 31, 2020 | 349.30M | -5.34% |
| Dec 31, 2019 | 369.00M | 66.59% |
| Dec 31, 2018 | 221.50M | 9.65% |
| Dec 29, 2017 | 202.00M | 9.78% |
| Dec 30, 2016 | 184.00M | 8.24% |
| Dec 31, 2015 | 170.00M | -2.02% |
| Dec 31, 2014 | 173.50M | -0.12% |
| Dec 31, 2013 | 173.70M | 44.03% |
| Dec 31, 2012 | 120.60M | 25.10% |
| Dec 30, 2011 | 96.40M | 27.18% |
| Dec 31, 2010 | 75.80M | 96.88% |
| Dec 31, 2009 | 38.50M | 29.19% |
| Dec 31, 2008 | 29.80M | -24.56% |
| Dec 31, 2007 | 39.50M | 36.68% |
| Dec 29, 2006 | 28.90M | 153.51% |
| Dec 30, 2005 | 11.40M | -35.23% |
| Dec 31, 2004 | 17.60M | 100.00% |
| Dec 31, 2003 | 8.80M | 95.56% |
| Dec 31, 2002 | 4.50M | - |
| Dec 31, 2001 | 4.50M | -39.19% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |